Short-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab

Clinical trial NCT06408584 · RECRUITING

Trial details

NCT number: NCT06408584
Sponsor: Anhui Provincial Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Esophageal Squamous Cell Carcinoma

Start date: 2024-03-01
Primary completion: 2027-03-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.